NTII Neurobiological Technologies (MM)

EMERYVILLE, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (NASDAQ:NTII), today announced it will release its second quarter 2008 financial results, for the quarter ended December 31, 2007, on February 11. The Company will host a conference call to discuss the earnings and to give a corporate update. Hosting the call will be Paul E. Freiman, President and Chief Executive Officer, and Craig W. Carlson, Vice President and Chief Financial Officer. The details for the call are as follows: Live Call: -- Date: Monday, February 11, 2008 -- Time: 10:30 a.m. ET, 9:30 a.m. CT, 7:30 a.m. PT -- Dial-in number: 877-857-6147 (U.S.) 719-325-4822 (International) Webcast of Call: -- A live webcast can be accessed online by going to: http://investor.shareholder.com/ntii/events.cfm The call will be archived and accessible at the same website for 90 days Telephonic Replay: A playback of the conference call will be available from 10:00 AM PT February 11th through midnight February 15, 2008. Replay number: 888-203-1112 (U.S. and Canada) / 719-457-0820 (international). Replay access code: 3898964. About Neurobiological Technologies, Inc. NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The Company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Walter Kass of Cordon Partners, LLC., +1-212-300-4708, for Neurobiological Technologies, Inc. Web site: http://www.ntii.com/

Copyright